Government and industry reach new pricing deal to cut NHS drugs billBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.a464 (Published 26 June 2008) Cite this as: BMJ 2008;336:1455
- Andrew Jack
- 1Financial Times
The government and the drug industry this week reached an outline agreement on a new contract for drug prices in the United Kingdom over the next five years. It is expected that the deal will cut the annual £9bn (€11bn; $18bn) drug bill in the UK’s health services by 5% by 2009.
The announcement follows a year of intense and tough negotiations after the Department of Health said it was unilaterally cancelling the current pharmaceutical price regulation scheme (PPRS) halfway through its planned duration (BMJ 2007;335:273 doi: 10.1136/bmj.39300.405822.DB).
The PPRS, which normally runs for five years, allows companies to set drug prices freely …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial